MedPath

Zeno Pharmaceuticals, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

A Study of ZN-e4 in Subjects With Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung Cancer

Phase 1
Completed
Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
First Posted Date
2018-02-26
Last Posted Date
2024-01-25
Lead Sponsor
Zeno Pharmaceuticals, Inc.
Target Recruit Count
34
Registration Number
NCT03446417
Locations
🇺🇸

Site 2, Duarte, California, United States

🇺🇸

Site 5, Detroit, Michigan, United States

🇺🇸

Site 1, East Setauket, New York, United States

and more 4 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.